Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Infective Endocarditis
2005 Standout
Heart Failure in Infective Endocarditis: Predisposing Factors, Course, and Treatment
1974
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
2006
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Nasopharyngeal carcinoma
2005 Standout
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
2001
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
The FGF family: biology, pathophysiology and therapy
2009 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines
1993 Standout
Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics
1992
Prevention of Radiation-Induced Oral Cavity Mucositis by Plasmid/Liposome Delivery of the Human Manganese Superoxide Dismutase (SOD2) Transgene
2003
Pancreatic cancer
2020 Standout
Quality of life bibliography and indexes: 1993 update
1995
The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity
1996
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Metabolism and action of amino acid analog anti-cancer agents
1990
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The Effect of Palifermin on Chemotherapyand Radiation Therapy–Induced Mucositis: A Review of the Current Literature
2007
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer
2001
Treatment of head and neck cancer: the role of chemotherapy
1996
Hematopoietic growth factors: ESMO Recommendations for the applications
2009
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Toxicity in head and neck cancer: a review of trends and issues
2000
A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
2017
Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer
1997
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
2005
Delivery technologies for cancer immunotherapy
2019 Standout
Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis
1992
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
2021 Nature
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Role of Combined-Modality Therapy in the Management of Locally Advanced Rectal Cancer
2008
Life-satisfaction in patients with head and neck cancer
1995
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
The pathobiology of mucositis
2004 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
2002
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Head and Neck Cancer
1993 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapy
1997
Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review
2013
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer
2003
Toxicity antagonists in head and neck cancer
1998
Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications
2010
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer Patients
1994
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Longitudinal assessment of quality of life in laryngeal cancer patients
1996
Head and Neck Cancer
2001 Standout
Bacterial Endocarditis at Blegdamshospitalet in Copenhagen 1944–1973
1976
Antibiotic Treatment of Infective Endocarditis
1983
Valve Replacement in Bacterial Endocarditis
1973
Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients
2005
Treatment of infective endocarditis: a 10-year comparative analysis.
1978 Standout
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.
2000
Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer
2000
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci.
1978
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Infective endocarditis with negative blood cultures
1979
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancer
1989
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update
2018
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
1999 Standout
Quality of Life and Performance in Advanced Head and Neck Cancer Patients on Concomitant Chemoradiotherapy: A Prospective Examination
1999
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Risk Factors for Infective Endocarditis
2000
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial
2000
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy
2004
Works of C. Cripps being referenced
Pretreatment with chemotherapy in patients with advanced head and neck cancer.
1985
Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer
2008
Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck
1992
A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer
2005
The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.
1993
A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)
2008
Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.
1994
A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
1984
Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
2006
Bacterial endocarditis 1956-1965: analysis of clinical features and treatment in relation to prognosis and mortality.
1969
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
2016
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
1984
A phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head & neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT)
2001